BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 2117633)

  • 1. HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells.
    Herman A; Croteau G; Sekaly RP; Kappler J; Marrack P
    J Exp Med; 1990 Sep; 172(3):709-17. PubMed ID: 2117633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Class II MHC molecules are specific receptors for staphylococcus enterotoxin A.
    Mollick JA; Cook RG; Rich RR
    Science; 1989 May; 244(4906):817-20. PubMed ID: 2658055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E.
    Karp DR; Long EO
    J Exp Med; 1992 Feb; 175(2):415-24. PubMed ID: 1370684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic shock syndrome toxin 1 binds to major histocompatibility complex class II molecules.
    Scholl P; Diez A; Mourad W; Parsonnet J; Geha RS; Chatila T
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4210-4. PubMed ID: 2542966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alpha 1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1.
    Karp DR; Teletski CL; Scholl P; Geha R; Long EO
    Nature; 1990 Aug; 346(6283):474-6. PubMed ID: 2377209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells.
    Subramanyam M; McLellan B; Labrecque N; Sekaly RP; Huber BT
    J Immunol; 1993 Sep; 151(5):2538-45. PubMed ID: 8395548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definition of sites on HLA-DR1 involved in the T cell response to staphylococcal enterotoxins E and C2.
    Hargreaves RE; Brehm RD; Tranter H; Warrens AN; Lombardi G; Lechler RI
    Eur J Immunol; 1995 Dec; 25(12):3437-44. PubMed ID: 8566035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of isotypic and allotypic variations of MHC class II molecules on staphylococcal enterotoxin presentation to murine T cells.
    Taub DD; Newcomb JR; Rogers TJ
    Cell Immunol; 1992 May; 141(2):263-78. PubMed ID: 1315622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative ability of distinct isotypes of human major histocompatibility complex class II molecules in binding staphylococcal enterotoxin A.
    Saito S; Imanishi K; Araake M; Yan XJ; Igarashi H; Uchiyama T
    Microbiol Immunol; 1991; 35(8):661-73. PubMed ID: 1753884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of human cytotoxic T lymphocytes to MHC class II-expressing cells by staphylococcal enterotoxins.
    Dohlsten M; Lando PA; Hedlund G; Trowsdale J; Kalland T
    Immunology; 1990 Sep; 71(1):96-100. PubMed ID: 2210803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization and role in T cell activation of staphylococcal enterotoxin A binding to the HLA-DR alpha-chain.
    Thibodeau J; Dohlsten M; Cloutier I; Lavoie PM; Bjork P; Michel F; Léveillé C; Mourad W; Kalland T; Sékaly RP
    J Immunol; 1997 Apr; 158(8):3698-704. PubMed ID: 9103433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of isotypes and allelic polymorphism on the binding of staphylococcal exotoxins to MHC class II molecules.
    Scholl PR; Diez A; Karr R; Sekaly RP; Trowsdale J; Geha RS
    J Immunol; 1990 Jan; 144(1):226-30. PubMed ID: 2404064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Position 71 in the alpha helix of the DR beta domain is predicted to influence peptide binding and plays a central role in allorecognition.
    Coppin HL; Carmichael P; Lombardi G; L'Faqihi FE; Salter R; Parham P; Lechler RI; de Preval C
    Eur J Immunol; 1993 Feb; 23(2):343-9. PubMed ID: 8436170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human major histocompatibility complex class II-negative colon carcinoma cells present staphylococcal superantigens to cytotoxic T lymphocytes: evidence for a novel enterotoxin receptor.
    Dohlsten M; Hedlund G; Segren S; Lando PA; Herrmann T; Kelly AP; Kalland T
    Eur J Immunol; 1991 May; 21(5):1229-33. PubMed ID: 1645269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of toxic shock syndrome toxin-1 to murine major histocompatibility complex class II molecules.
    Scholl PR; Sekaly RP; Diez A; Glimcher LH; Geha RS
    Eur J Immunol; 1990 Sep; 20(9):1911-6. PubMed ID: 2209697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between staphylococcal superantigens and MHC class II molecules.
    Labrecque N; Thibodeau J; Sékaly RP
    Semin Immunol; 1993 Feb; 5(1):23-32. PubMed ID: 8467091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen.
    Gay D; Maddon P; Sekaly R; Talle MA; Godfrey M; Long E; Goldstein G; Chess L; Axel R; Kappler J
    Nature; 1987 Aug 13-19; 328(6131):626-9. PubMed ID: 3112582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different staphylococcal enterotoxins bind preferentially to distinct major histocompatibility complex class II isotypes.
    Herrmann T; Accolla RS; MacDonald HR
    Eur J Immunol; 1989 Nov; 19(11):2171-4. PubMed ID: 2599004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staphylococcal enterotoxin B and toxic shock syndrome toxin-1 bind to distinct sites on HLA-DR and HLA-DQ molecules.
    Scholl PR; Diez A; Geha RS
    J Immunol; 1989 Oct; 143(8):2583-8. PubMed ID: 2551962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
    Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
    J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.